Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

40 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Targeting p53 and histone methyltransferases restores exhausted CD8+ T cells in HCV infection.
Barili V, Fisicaro P, Montanini B, Acerbi G, Filippi A, Forleo G, Romualdi C, Ferracin M, Guerrieri F, Pedrazzi G, Boni C, Rossi M, Vecchi A, Penna A, Zecca A, Mori C, Orlandini A, Negri E, Pesci M, Massari M, Missale G, Levrero M, Ottonello S, Ferrari C. Barili V, et al. Nat Commun. 2020 Jan 30;11(1):604. doi: 10.1038/s41467-019-14137-7. Nat Commun. 2020. PMID: 32001678 Free PMC article.
Natural killer cell phenotype modulation and natural killer/T-cell interplay in nucleos(t)ide analogue-treated hepatitis e antigen-negative patients with chronic hepatitis B.
Boni C, Lampertico P, Talamona L, Giuberti T, Invernizzi F, Barili V, Fisicaro P, Rossi M, Cavallo MC, Vecchi A, Pedrazzi G, Alfieri A, Colombo M, Missale G, Ferrari C. Boni C, et al. Among authors: barili v. Hepatology. 2015 Dec;62(6):1697-709. doi: 10.1002/hep.28155. Epub 2015 Oct 29. Hepatology. 2015. PMID: 26361374
Targeting mitochondrial dysfunction can restore antiviral activity of exhausted HBV-specific CD8 T cells in chronic hepatitis B.
Fisicaro P, Barili V, Montanini B, Acerbi G, Ferracin M, Guerrieri F, Salerno D, Boni C, Massari M, Cavallo MC, Grossi G, Giuberti T, Lampertico P, Missale G, Levrero M, Ottonello S, Ferrari C. Fisicaro P, et al. Among authors: barili v. Nat Med. 2017 Mar;23(3):327-336. doi: 10.1038/nm.4275. Epub 2017 Feb 6. Nat Med. 2017. PMID: 28165481
T cell regulation in HBV-related chronic liver disease.
Ferrari C, Boni C, Rossi M, Vecchi A, Barili V, Laccabue D, Fisicaro P, Missale G. Ferrari C, et al. Among authors: barili v. J Hepatol. 2017 May;66(5):1096-1098. doi: 10.1016/j.jhep.2016.10.002. Epub 2017 Feb 8. J Hepatol. 2017. PMID: 28189261 No abstract available.
Combined GS-4774 and Tenofovir Therapy Can Improve HBV-Specific T-Cell Responses in Patients With Chronic Hepatitis.
Boni C, Janssen HLA, Rossi M, Yoon SK, Vecchi A, Barili V, Yoshida EM, Trinh H, Rodell TC, Laccabue D, Alfieri A, Brillo F, Fisicaro P, Acerbi G, Pedrazzi G, Andreone P, Cursaro C, Margotti M, Santoro R, Piazzolla V, Brunetto MR, Coco B, Cavallone D, Zhao Y, Joshi A, Woo J, Lau AH, Gaggar A, Subramanian GM, Massetto B, Fung S, Ahn SH, Ma X, Mangia A, Ferrari C. Boni C, et al. Among authors: barili v. Gastroenterology. 2019 Jul;157(1):227-241.e7. doi: 10.1053/j.gastro.2019.03.044. Epub 2019 Mar 28. Gastroenterology. 2019. PMID: 30930022 Free article. Clinical Trial.
HBV Immune-Therapy: From Molecular Mechanisms to Clinical Applications.
Boni C, Barili V, Acerbi G, Rossi M, Vecchi A, Laccabue D, Penna A, Missale G, Ferrari C, Fisicaro P. Boni C, et al. Among authors: barili v. Int J Mol Sci. 2019 Jun 5;20(11):2754. doi: 10.3390/ijms20112754. Int J Mol Sci. 2019. PMID: 31195619 Free PMC article. Review.
40 results